1 completed, 1 recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow ASK120067: new trials by email Literature Review of ASK120067 trials Research Report on ASK120067
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 With or Without ASK120067 ASKC202, ASK120067 - Advanced Solid Tumor | Phase 1 | Recruiting | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 150 | 2022-08-08 | 2025-12-23 |
| Assessing the Pharmacokinetics Effects of Food on ASK120067 in Single Oral Administration in Chinese Healthy Subjects ASK120067, ASK120067 in fed condition - Locally Advanced or Metastatic NSCLC | Phase 1 | Completed | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 24 | 2019-12-09 | 2020-04-29 |
| Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer ASK120067 - Locally Advanced or Metastatic NSCLC | Phase 1 / Phase 2 | Unknown | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 507 | 2017-11-30 | 2020-09-16 |
Carcinoma, Non-Small-Cell Lung (2)
Jiangsu Aosaikang Pharmaceutical Co., Ltd. (3)
China (3)
Zhou Caicun, MD (1) · Zourong Ruan (1)